1. A novel antibody–drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity
    Linlin Jiang et al, 2016, Journal of Drug Targeting CrossRef
  2. Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates
    Ajeeth Adhikari et al, 2021, Antibody Therapeutics CrossRef